Seeking Alpha
 

Endologix Inc (ELGX)

- NASDAQ
Show Summaries  |  Hide Summaries
  • Sep. 29, 2014, 12:49 PM
    | Comment!
  • Feb. 28, 2014, 12:59 PM
  • Feb. 28, 2014, 12:46 PM
    | 5 Comments
  • Feb. 28, 2014, 9:14 AM
    | Comment!
  • Feb. 27, 2014, 5:38 PM
    | Comment!
  • May 1, 2013, 9:10 AM
    Premarket gainers: IQNT +34%. MSPD +31%. TRLA +14%. FIRE +12%. JRCC +11%. CAAS +8%. DWA +9%. GDOT +8%. CAVM +8%. NAVB +5%.
    Losers: HIMX -9%. ELGX -8%. SWI -8%.
    | Comment!
  • Jan. 28, 2013, 12:37 PM
    Endologix (ELGX +2.3%) presents data from its clinical trial of a totally percutaneous approach to endovascular abdominal aortic aneurysm repair, says the study demonstrated that the approach is non-inferior to surgical endovascular repair, and also has significantly reduced procedure times and time to hemostasis. The study also demonstrated positive trends toward lower blood loss, less need for pain medication, and shorter lengths of stay.
    | Comment!
  • Dec. 31, 2012, 2:59 PM
    Endologix (ELGX +1%) says its distribution partner in Japan, Cosmotec, has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare to market the IntuiTrak Delivery System. The IntuiTrak System delivers ELGX's Powerlink anatomical fixation stent graft for the repair of abdominal aortic aneurysms.
    | Comment!
  • Jun. 12, 2012, 1:27 PM
    Endologix (ELGX +1.8%) pipeline looks impressive, says Oppenheimer. After meeting with management, the firm says ELGX's growth story remains intact and that abdominal aortic aneurysm market volumes and pricing remain solid. The firm thinks the Street is still underestimating the value of the company's Nelix treatment and reiterates a Buy on the stock.
    | Comment!
  • Feb. 2, 2012, 9:00 AM
    Premarket gainers: GMCR +21%. CEDC +21%. MTSN +15%. OMEX +10%. GPS +8%. CNQR +6%. EA +6%. CDNS +6%. QCOM +5%. ELGX +5%. GFA +5%. AUO +4%. KSS +4%. ZNGA +4%. IRE +4%. CMI +3%. K +3%. CPST +3%. JDSU +3%. MA +3%. RENN +3%.
    Losers: SD -13%. ANF -12%. ANN -10%. NG -9%. BSX -6%. CI -6%. RCL -6%. UN -5%. MPW +4%. VIA -4%. UL -4%. CHKM -4%. SNE -4%. PCX -4%. PHM -3%. DOW -3%. ANZ -3%. CUK -3%. CCL -3%. NBG -3%.
    | Comment!
Visit Seeking Alpha's
ELGX vs. ETF Alternatives
Company Description
Endologix Inc develops, manufactures, markets & sells medical devices for the treatment of aortic disorders. ItsEVAR products include the Endologix AFX Endovascular AAA System (AFX) and the Endologix Powerlink with Intuitrak Delivery System.